Wells Fargo & Company Eli Lilly & CO Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Eli Lilly & CO stock. As of the latest transaction made, Wells Fargo & Company holds 444,100 shares of LLY stock, worth $355 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

444,100

Previous 2,967,541 85.03%

Holding current value

$355 Million

Previous $2.69 Billion 85.36%

% of portfolio

0.09%

Previous 0.66%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $18.5 Million - $23 Million	-23,992 Reduced 0.81%	2,943,549 $2.61 Billion
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $34 Million - $42.6 Million	46,841 Added 1.6%	2,967,541 $2.69 Billion
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $75.3 Million - $101 Million	-127,130 Reduced 4.17%	2,920,700 $2.27 Billion
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $69.7 Million - $82.2 Million	132,699 Added 4.55%	3,047,830 $1.78 Billion
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $60 Million - $82.7 Million	-137,918 Reduced 4.52%	2,915,131 $1.57 Billion
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $18.4 Million - $24.7 Million	52,574 Added 1.75%	3,053,049 $1.43 Billion
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $5.91 Million - $6.94 Million	-19,016 Reduced 0.63%	3,000,475 $1.03 Billion
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $3.29 Million - $3.83 Million	-10,227 Reduced 0.34%	3,019,491 $1.1 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $49.9 Million - $56.8 Million	-168,172 Reduced 5.26%	3,029,718 $980 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $17.1 Million - $20 Million	-61,248 Reduced 1.88%	3,197,890 $1.04 Billion
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $28.5 Million - $35.5 Million	121,649 Added 3.88%	3,259,138 $933 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $31.8 Million - $39.4 Million	-141,319 Reduced 4.31%	3,137,489 $867 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $24 Million - $29.5 Million	-108,148 Reduced 3.19%	3,278,808 $758 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $82.7 Million - $107 Million	-458,312 Reduced 11.92%	3,386,956 $777 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $86.8 Million - $112 Million	-527,946 Reduced 12.07%	3,845,268 $718 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $26.1 Million - $34.5 Million	-199,710 Reduced 4.37%	4,373,214 $738 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $25.2 Million - $29.2 Million	172,577 Added 3.92%	4,572,924 $677 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $66.8 Million - $80.4 Million	489,799 Added 12.53%	4,400,347 $722 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $466 Million - $576 Million	3,910,548 New	3,910,548 $542 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Eli Lilly & CO Transaction History